Engineering the Modular Receptor-Binding Proteins of Klebsiella Phages Switches Their Capsule Serotype Specificity
Author(s)
Latka, Agnieszka; Lemire, Sebastien; Grimon, Dennis; Dams, Dorien; Maciejewska, Barbara; Lu, Timothy; Drulis-Kawa, Zuzanna; Briers, Yves; ... Show more Show less
DownloadPublished version (1.856Mb)
 Publisher with Creative Commons License
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
<jats:p>The antimicrobial resistance crisis has rekindled interest in bacteriophage therapy. Phages have been studied over a century as therapeutics to treat bacterial infections, but one of the biggest challenges for the use of phages in therapeutic interventions remains their high specificity.</jats:p>
Date issued
2021Department
Massachusetts Institute of Technology. Synthetic Biology Center; Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science; Massachusetts Institute of Technology. Department of Biological Engineering; Massachusetts Institute of Technology. Research Laboratory of Electronics; Singapore-MIT Alliance in Research and Technology (SMART)Journal
mBio
Publisher
American Society for Microbiology
Citation
Latka, Agnieszka, Lemire, Sebastien, Grimon, Dennis, Dams, Dorien, Maciejewska, Barbara et al. 2021. "Engineering the Modular Receptor-Binding Proteins of Klebsiella Phages Switches Their Capsule Serotype Specificity." mBio, 12 (3).
Version: Final published version